COZAAR

This brand name is authorized in Brazil, Canada, Cyprus, Germany, Ecuador, Spain, Finland, France, Hong Kong, Ireland, Mexico, Netherlands, Poland, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug COZAAR contains one active pharmaceutical ingredient (API):

1 Losartan
UNII 3ST302B24A - LOSARTAN POTASSIUM

Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.

Read about Losartan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
COZAAR Powder and solvent for oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
COZAAR Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
COZAAR Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C09CA01 Losartan C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 525500601116311, 525500605111312, 525500606118310
Country: CA Health Products and Food Branch Identifier(s): 02182815, 02182874, 02182882
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00634070
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 24.355-1-01-12, 366780713
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60913, 62117, 64971
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 006928, 079061
Country: FR Base de données publique des médicaments Identifier(s): 66928996, 69197614
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 13583, 13584, 138569, 138571, 142112, 151391, 180547, 198701, 373503, 373620, 374050, 381275, 399367, 94152
Country: HK Department of Health Drug Office Identifier(s): 39953, 50281
Country: IE Health Products Regulatory Authority Identifier(s): 19020, 19042, 19051, 19065, 19252, 19257, 76510, 76511, 76529
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 284M95
Country: NL Z-Index G-Standaard, PRK Identifier(s): 41890, 60569
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100016067, 100113936, 100124555
Country: SG Health Sciences Authority Identifier(s): 08588P, 11614P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8683280337053, 8683280337060
Country: US FDA, National Drug Code Identifier(s): 0006-0951, 0006-0952, 0006-0960, 55289-238
Country: ZA Health Products Regulatory Authority Identifier(s): 29/7.1.3/0268, 36/7.1.3/0490

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.